17-P (Reduce Preterm Births)

The objective of this project is to improve the use of 17-OH progesterone in women at risk for preterm birth. This working group will assess needs in the state, barriers to uptake, and strategies to increase utilization of the medication. Data to be collected will be global use of 17-OH P in the state as well as the preterm birth rate.

Key Activities

  1. Construction of 17OHP current process flow diagram
  2. Create Universal Prior Authorization form


  1. Determine current progesterone usage data for VA
  2. Recruit geographically specific clinics to participate in data collection
  3. Determine process improvement options


Marie Pokraka RN, MSN, IBCLC  | March of Dimes

Cathleen McCoy, MD | Winchester Medical Center